Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Eli Lilly
Pharmaceuticals
Novo Nordisk
GSK
AstraZeneca
Topics

Advertisement

Advertisement

Eli Lilly

Share

Top Latest Popular

Eli Lilly obesity drug data adds pressure on Novo Nordisk Proactive Investors (US) 2d

Proactive Investors (US) 2d

Novo Nordisk Pharma

Lilly's Foundayo pill matched insulin on heart safety in Lancet trial, but its lower death rate needs caution Medical Daily 2d

Medical Daily 2d

The Lancet Pharma

Federal Circuit denies en banc rehearing in Teva v. Eli Lilly, preserving precedent for method-of-treatment patent claims JD Supra 3d

JD Supra 3d

Teva Federal Circuit

Advertisement

Advertisement

Lilly's Foundayo pill linked to 57% lower predicted diabetes risk in attain-1 modeling, but no cases were counted Medical Daily 14h

Medical Daily 14h

Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial STAT 4d

STAT 4d

New Lilly combo tops tirzepatide for weight loss in diabetes pharmaphorum 3d

pharmaphorum 3d

Advertisement

Advertisement

Latest

In the last 4 hours

Eli Lilly Just Announced Something Big. Here’s What It Means for Investors. The Motley Fool 10:17

Earlier Today

Lilly's Foundayo Pill Linked to 57% Lower Predicted Diabetes Risk in ATTAIN-1 Modeling, but No Cases Were Counted Medical Daily 00:06

Yesterday

Lilly's Ebglyss Cleared or Nearly Cleared Hand and Foot Eczema in 53% of Patients Versus 27% on Placebo Medical Daily 18:08 Sat, 03 Oct

Friday

Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors The Motley Fool 21:27 Fri, 02 Oct

Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent Btk inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/Sll PR Newswire (Press Release) 20:08 Fri, 02 Oct

Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes Medical Daily 19:56 Fri, 02 Oct

Lilly's Foundayo Pill Matched Insulin on Heart Safety in Lancet Trial, but Its Lower Death Rate Needs Caution Medical Daily 19:56 Fri, 02 Oct

February 2027 Options Now Available For Eli Lilly (LLY) Nasdaq 15:59 Fri, 02 Oct

Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant NL Times 08:55 Fri, 02 Oct

Eli Lilly obesity drug data adds pressure on Novo Nordisk Proactive Investors (US) 07:38 Fri, 02 Oct

Advertisement

Advertisement

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis